NDC 44911-0530

CARCINOSIN CORD

Carcinosin

CARCINOSIN CORD is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Energique, Inc.. The primary component is Human Breast Tumor Cell.

Product ID44911-0530_d07c77d7-1cee-4114-846e-5fd9f30a9305
NDC44911-0530
Product TypeHuman Otc Drug
Proprietary NameCARCINOSIN CORD
Generic NameCarcinosin
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2020-01-15
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameEnergique, Inc.
Substance NameHUMAN BREAST TUMOR CELL
Active Ingredient Strength12 [hp_X]/mL
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 44911-0530-1

60 mL in 1 BOTTLE, DROPPER (44911-0530-1)
Marketing Start Date2020-01-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 44911-0530-1 [44911053001]

CARCINOSIN CORD LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2020-01-15

Drug Details

Active Ingredients

IngredientStrength
HUMAN BREAST TUMOR CELL12 [hp_X]/mL

NDC Crossover Matching brand name "CARCINOSIN CORD" or generic name "Carcinosin"

NDCBrand NameGeneric Name
44911-0191CARCINOSIN CORDCarcinosin
44911-0530CARCINOSIN CORDCarcinosin
43742-0208CarcinosinCarcinosin
43742-0676CarcinosinCarcinosin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.